| Primary |
| Type 2 Diabetes Mellitus |
47.5% |
| Diabetes Mellitus |
22.2% |
| Diabetes Mellitus Non-insulin-dependent |
11.8% |
| Drug Use For Unknown Indication |
2.7% |
| Hypertension |
2.7% |
| Blood Glucose Increased |
1.8% |
| Product Used For Unknown Indication |
1.4% |
| Type 1 Diabetes Mellitus |
1.4% |
| Depression |
0.9% |
| Diabetes Mellitus Inadequate Control |
0.9% |
| Diabetic Neuropathy |
0.9% |
| Glucose Tolerance Impaired |
0.9% |
| Hepatitis C |
0.9% |
| Insulin Resistance |
0.9% |
| Uterine Haemorrhage |
0.9% |
| Type 2 Diabetes Mellitus |
0.5% |
| Bladder Cancer |
0.5% |
| Diabetes Mellitus Management |
0.5% |
| Glaucoma |
0.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.5% |
|
| Bladder Cancer |
28.6% |
| Weight Increased |
8.0% |
| Pharmaceutical Product Complaint |
7.1% |
| Myocardial Infarction |
6.3% |
| Weight Decreased |
5.4% |
| Bladder Transitional Cell Carcinoma |
4.5% |
| Malaise |
3.6% |
| Myalgia |
3.6% |
| Somnolence |
3.6% |
| Urticaria |
3.6% |
| Vomiting |
3.6% |
| Angioedema |
2.7% |
| Cardiac Failure Congestive |
2.7% |
| Death |
2.7% |
| Hepatic Neoplasm Malignant |
2.7% |
| Renal Failure |
2.7% |
| Tachycardia |
2.7% |
| Treatment Noncompliance |
2.7% |
| Atrial Fibrillation |
1.8% |
| Benign Prostatic Hyperplasia |
1.8% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
23.3% |
| Diabetes Mellitus |
16.5% |
| Product Used For Unknown Indication |
12.6% |
| Diabetes Mellitus Non-insulin-dependent |
11.7% |
| Drug Use For Unknown Indication |
10.7% |
| Hypertension |
3.9% |
| Depression |
2.9% |
| Dyslipidaemia |
2.9% |
| Blood Cholesterol Increased |
1.9% |
| Diabetes Mellitus Management |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Tachyarrhythmia |
1.9% |
| Arthralgia |
1.0% |
| Arthritis |
1.0% |
| Blood Cholesterol Abnormal |
1.0% |
| Blood Glucose |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Burning Sensation |
1.0% |
| H1n1 Influenza |
1.0% |
| High Density Lipoprotein Decreased |
1.0% |
|
| Bladder Cancer |
13.2% |
| Oedema Peripheral |
10.5% |
| Macular Oedema |
7.9% |
| Weight Decreased |
7.9% |
| Weight Increased |
7.9% |
| Eczema |
5.3% |
| Flushing |
5.3% |
| Pain |
5.3% |
| Pancytopenia |
5.3% |
| Renal Failure Acute |
5.3% |
| Attention Deficit/hyperactivity Disorder |
2.6% |
| Bladder Transitional Cell Carcinoma |
2.6% |
| Blood Glucose Decreased |
2.6% |
| Blood Glucose Increased |
2.6% |
| Blood Potassium Increased |
2.6% |
| Diarrhoea |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Drug Ineffective |
2.6% |
| Faecal Incontinence |
2.6% |
| Headache |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.8% |
| Drug Use For Unknown Indication |
18.6% |
| Diabetes Mellitus |
10.0% |
| Diabetes Mellitus Non-insulin-dependent |
8.1% |
| Type 2 Diabetes Mellitus |
7.9% |
| Hypertension |
5.8% |
| Blood Cholesterol Increased |
3.9% |
| Prophylaxis |
1.7% |
| Blood Triglycerides Increased |
1.5% |
| High Density Lipoprotein Decreased |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Depression |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Psoriasis |
1.3% |
| Vitamin Supplementation |
1.2% |
| Pain |
1.0% |
| Blood Cholesterol |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Bipolar Disorder |
0.8% |
| Anxiety |
0.7% |
|
| Weight Decreased |
24.9% |
| Flushing |
10.5% |
| Blood Glucose Increased |
8.9% |
| Vomiting |
8.9% |
| Nausea |
6.2% |
| Pruritus |
5.1% |
| Weight Increased |
5.1% |
| Vision Blurred |
3.5% |
| Drug Ineffective |
3.1% |
| Rash |
2.7% |
| Muscle Spasms |
2.3% |
| Myalgia |
2.3% |
| Pancreatitis |
2.3% |
| Rhinorrhoea |
2.3% |
| Catheterisation Cardiac |
1.9% |
| Dyspnoea |
1.9% |
| Hyperhidrosis |
1.9% |
| Psychomotor Skills Impaired |
1.9% |
| Skin Burning Sensation |
1.9% |
| Syncope |
1.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
42.9% |
| Blood Cholesterol Increased |
28.6% |
| Diabetes Mellitus |
14.3% |
| Hypertension |
14.3% |
|
| Oedema Peripheral |
33.3% |
| Renal Disorder |
33.3% |
| Rhabdomyolysis |
33.3% |
|
